Immunocore Holdings plc
IMCR
$33.97
-$0.50-1.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.02% | -27.46% | 30.48% | 37.88% | 62.99% |
| Total Depreciation and Amortization | -5.97% | -16.98% | -22.31% | -11.60% | -6.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.42% | 99.62% | 28.53% | -37.89% | -52.62% |
| Change in Net Operating Assets | -255.60% | -195.12% | -119.00% | -59.05% | 28.74% |
| Cash from Operations | -204.12% | -180.18% | -141.10% | -64.13% | 198.68% |
| Capital Expenditure | -20.90% | -15.51% | 16.10% | -109.64% | -186.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.00% | 95.29% | 96.57% | 96.00% | 94.29% |
| Cash from Investing | 131.12% | 93.67% | 95.40% | 94.61% | 92.87% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 234.21% | 191.24% | 81.93% | -30.93% | -69.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | 151.65% | 121.13% | -96.40% | -110.81% | -110.95% |
| Foreign Exchange rate Adjustments | -95.66% | 60.93% | 1,660.83% | -31.80% | 1,039.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.33% | 93.21% | -8.60% | -142.03% | -123.36% |